Cargando…

Current Progress of Studies of Coronary CT for Risk Prediction of Major Adverse Cardiovascular Event (MACE)

Cardiovascular disease is a serious threat to human health, and early risk prediction of major adverse cardiovascular event in people suspected of coronary heart disease can help guide prevention and clinical decisions. Coronary computed tomography (CT) is a useful imaging tool for evaluation of cor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Jianan, Lu, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Echocardiography 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592676/ https://www.ncbi.nlm.nih.gov/pubmed/34719895 http://dx.doi.org/10.4250/jcvi.2021.0016

Ejemplares similares

MACE in the Race: A Canadian Perspective on Major Adverse Cardiac Events (MACE) During Running
por: Abrahim, Mohammed
Publicado: (2022)

Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study
por: Farshidi, Hossein, et al.
Publicado: (2018)

A prediction model for major adverse cardiovascular events (MACE) in patients with coronavirus disease 2019 (COVID-19)
por: Huang, Dong, et al.
Publicado: (2022)

Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE)
por: Chen, Dongqing, et al.
Publicado: (2023)

Risk prediction model for major adverse cardiovascular events (MACE) during hospitalization in patients with coronary heart disease based on myocardial energy metabolic substrate
por: Na, Li, et al.
Publicado: (2023)

Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes
por: Xie, Gaoqiang, et al.
Publicado: (2017)

Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights
por: Marsal, Josep Ramon, et al.
Publicado: (2022)

Association of Race and Major Adverse Cardiac Events (MACE): The Atherosclerosis Risk in Communities (ARIC) Cohort
por: Franey, Ericha G, et al.
Publicado: (2020)

Major Adverse Cardiovascular Events (MACE) in COVID-19 Infection and the Role of Cardiac Biomarkers: A Systematic Literature Review
por: Mahendran, S., et al.
Publicado: (2021)

Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial
por: Schwartz, Gregory G., et al.
Publicado: (2021)

Reduction of Major Adverse Cardiovascular Events (MACE) after Bariatric Surgery in Patients with Obesity and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Sutanto, Andryanto, et al.
Publicado: (2021)

331 A Machine Learning-based Pharmacogenomic Association Study of Major Adverse Cardiovascular Events (MACEs) in Caribbean Hispanic Patients on Clopidogrel
por: Arroyo, Luis A. Rosario, et al.
Publicado: (2022)

Combination of coronary CT angiography, FFR(CT), and risk factors in the prediction of major adverse cardiovascular events in patients suspected CAD
por: Wada, Shinichi, et al.
Publicado: (2023)

4423 Impact of Gender on High On-Treatment Platelet Reactivity (HPR) and Major Adverse Cardiovascular Events (MACEs) in Caribbean Hispanic patients using Clopidogrel
por: Nunez Medina, Hector Jose, et al.
Publicado: (2020)

Retrospective Study of Appropriate Primary Prevention in Postmenopausal Women Presenting with a Major Adverse Cardiovascular Endpoint (MACE)
por: Cieri-Hutcherson, Nicole E., et al.
Publicado: (2022)

Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin
por: Sardu, Celestino, et al.
Publicado: (2019)

The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD Readmissions
por: Kallis, Constantinos, et al.
Publicado: (2023)

Risk of a major adverse cardiovascular event (MACE) following first-ever hospitalisation for acute gout: a Western Australian population-level linked data study.
por: Lopez, Derrick, et al.
Publicado: (2022)

Utilizing Chinese Admission Records for MACE Prediction of Acute Coronary Syndrome
por: Hu, Danqing, et al.
Publicado: (2016)

Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study
por: Reyes, Luis Felipe, et al.
Publicado: (2023)

O054 What Measure of CPAP Treatment is most closely Associated with Reduced Risk of Future Major Cardiovascular Events (MACE)?
por: Reynor, A, et al.
Publicado: (2023)

Association between high sensitivity C-reactive protein (hs-CRP) levels and the risk of major adverse cardiovascular events (MACE) and/or microembolic signals after carotid angioplasty and stenting
por: Foroughinia, Farzaneh, et al.
Publicado: (2019)

Evidential MACE prediction of acute coronary syndrome using electronic health records
por: Hu, Danqing, et al.
Publicado: (2019)

CT-derived fractional flow reserve for prediction of major adverse cardiovascular events in diabetic patients
por: Lan, Ziting, et al.
Publicado: (2023)

Utilizing dynamic treatment information for MACE prediction of acute coronary syndrome
por: Duan, Huilong, et al.
Publicado: (2019)

Prediction of Coronary Artery Disease and Major Adverse Cardiovascular Events Using Clinical and Genetic Risk Scores for Cardiovascular Risk Factors
por: Ramírez, Julia, et al.
Publicado: (2022)

Coronary CT angiography and serum biomarkers are potential biomarkers for predicting MACE at three-months and one-year follow-up
por: Huang, Honglei, et al.
Publicado: (2022)

CT-Based Leiden Score Outperforms Confirm Score in Predicting Major Adverse Cardiovascular Events for Diabetic Patients with Suspected Coronary Artery Disease
por: Liu, Zinuan, et al.
Publicado: (2022)

Risk factors for major adverse cardiovascular events after the first acute coronary syndrome
por: Okkonen, Marjo, et al.
Publicado: (2021)

Monocyte to High-Density Lipoprotein Ratio (MHR) as a predictor of mortality and Major Adverse Cardiovascular Events (MACE) among ST Elevation Myocardial Infarction (STEMI) patients undergoing primary percutaneous coronary intervention: a meta-analysis
por: Villanueva, Danielle Louis E., et al.
Publicado: (2020)

Rhinitis induced to mace
por: Sanchez Moreno, Gema Vanesa, et al.
Publicado: (2011)

Homocysteine as a potential predictive factor for high major adverse cardiovascular events risk in female patients with premature acute coronary syndrome
por: Wei, Mei, et al.
Publicado: (2019)

Elevated serum FGF21 predicts the major adverse cardiovascular events in STEMI patients after emergency percutaneous coronary intervention
por: Gu, Lingyun, et al.
Publicado: (2021)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
por: Chen, Zhihao, et al.
Publicado: (2018)

Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
por: Cai, Anping, et al.
Publicado: (2019)

Risk Prediction of Major Adverse Cardiovascular Events Occurrence Within 6 Months After Coronary Revascularization: Machine Learning Study
por: Wang, Jinwan, et al.
Publicado: (2022)

Effects of opium use on one-year major adverse cardiovascular events (MACE) in the patients with ST-segment elevation MI undergoing primary PCI: a propensity score matched - machine learning based study
por: Jenab, Yaser, et al.
Publicado: (2023)

The association between 24-h blood pressure variability and major adverse cardiac events (MACE) in hospitalized patients with acute myocardial infarction: a retrospective cohort study
por: Harefa, et al.
Publicado: (2021)

A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
por: Kong, Shuting, et al.
Publicado: (2021)

Using Machine Learning Techniques to Predict MACE in Very Young Acute Coronary Syndrome Patients
por: Juan-Salvadores, Pablo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4rj842au3t9ljqtncgeh9dg81r